“Our finding that about a third of patients had some evidence of spermatogenesis in the testes at the time of bilateral simple orchiectomy indicates that there is at least some fertility potential in these patients," says Tristan Nicholson, MD, PhD.
Treatment combining the immunotherapy atezolizumab (Tecentriq) and platinum-based chemotherapy significantly improved progression-free survival in patients with previously untreated locally advanced or metastatic urothelial carcinoma compared to chemotherapy alone.
The magnetic resonance imaging pathway is the most accurate diagnostic strategy for detecting clinically significant prostate cancer, according to a recent literature review.
Researchers have identified a urine biomarker that noninvasively helps detect aggressive prostate cancer about as accurately as tissue-based prognostic markers, according to a recent study.
Low-intensity extracorporeal shock wave therapy is a safe treatment for men with erectile dysfunction and might work to improve, or even cure, ED in some patients. But there remain important unanswered questions, including which patients are ideal candidates and which protocol and devices are best.
The novel antibody-drug conjugate enfortumab vedotin produced an impressive 44% response rate in a phase II trial of urothelial cancer patients who had been treated with standard chemotherapy and a checkpoint inhibitor.
Smoking’s strong impact on bladder cancer risk among men and women is clear, but a new study shows quitting smoking can greatly reduce risk of the cancer among menopausal women.
Few physicians will argue that prior authorization is an administrative headache. Now, however, there are mounting data showing that prior authorization does more harm than good.
David J. Zetter, Jonathan Rubenstein, MD, and Mark Painter share their advice.
Urology practices are among the health care entities accused of violating the False Claims Act in recent years. And they’ve paid the price.